Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
09/2008
09/23/2008US7427631 especially as inhibitors of MMP12
09/23/2008US7427618 e.g. 2-[3-(4-ethynylphenyl)ureido]-N-[4-(3-oxomorpholin-4-yl)phenyl]valeramide; anticoagulant, antitumor factor; thromboses, myocardial infarction, arteriosclerosis, inflammation, apoplexy, angina pectoris, restenosis after angioplasty, claudicatio intermittens, or migraine
09/23/2008US7427612 Such as 1-(4-{4-[2-(cyclopropylmethyl-amino)-5-nitro-benzoyl]-piperazin-1-yl}-3-fluoro- phenyl)-ethanone for treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia, attention deficit disorders, or Alzheimer's disease
09/23/2008US7427394 Delivering labile agents; buffering effect; transfecting nucleic acids; nontoxic
09/23/2008CA2450093C Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
09/23/2008CA2378382C Carboxylic acid amides, pharmaceutical compositions containing these compounds, the use and preparation thereof
09/18/2008WO2008112674A1 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
09/18/2008WO2008111794A1 4-methylimidazol-5-ylcarbonylguanidine derivatives, pharmaceutically acceptable salts thereof, preparation method, and pharmaceutical compositions for the prevention and treatment of the ischemic heart diseases containing the same as an active ingredient
09/18/2008WO2008111414A1 Catalyst composition, and process for production of cross-coupling compound using the same
09/18/2008WO2008110698A2 Method for preparing fluorinated sulphanylamides and sulphinamidines and uses thereof
09/18/2008WO2008110466A1 Nitroxides for lithium-ion batteries
09/18/2008WO2008110062A1 Compounds with partial agonist activity of pparϝ and application thereof
09/18/2008WO2008110007A1 Imidazolium-type ionic oligomers
09/18/2008WO2008052863A3 Method for reacting 1,3-heteroaromatic 2-carboxylates with water
09/18/2008US20080227987 Process for the Preparation of Onium Alkylsulfites
09/18/2008US20080227793 2-(1-Imidazomethyl)- or 2-(1-imidazooxy)-substituted, e.g., 6-chloro-2-{[2-(2-fluorophenyl)-1H-imidazol-1-yl]methyl}-1-propyl1H-benzimidazole; GABA receptor signal transduction; anxiety, antidepressants, sleep disorders, schizophrenia, attention deficit-hyperactivity disorder, memory enhancement
09/18/2008US20080227781 Imidazole compounds for the treatment of neurodegenerative disorders
09/18/2008US20080226716 Gamma aminobutyric acid antagonist such as naphthylalanine; antiepileptic agents; antidepressants; anxiolytic agents; psychological disorders; neurodegenerative diseases; analgesics; drug withdrawal
09/18/2008US20080226618 Hydantoin derivatives useful as antibacterial agents
09/18/2008CA2679526A1 Nitroxides for lithium-ion batteries
09/18/2008CA2677295A1 Method for preparing fluorinated sulphanylamides and sulphinamidines and uses thereof
09/17/2008EP1968963A1 Substituted propiolic acid amides and their use for producing analgesics
09/17/2008EP1968947A1 Gaba-b receptor modulators
09/17/2008EP1968946A1 Imidazoles as gaba-b receptor modulators
09/17/2008EP1968945A2 Muscarinic receptor antagonists
09/17/2008EP1968935A1 Substituted bis(hetero)aromatic n-ethylpropiolamides and use thereof for production of medicaments
09/17/2008EP1824827B1 Method for producing onium salts comprising alkyl anions or aryl sulfonate anions or alkyl anions or aryl carboxylate anions having a low halide content
09/17/2008EP1791825B1 Benzoyl-substituted serine amides
09/17/2008EP1392639B1 Pyruvate derivatives
09/17/2008CN101268066A A process for the preparation of sartan derivatives and intermediates useful in such process
09/17/2008CN101268057A Ionic liquids
09/17/2008CN101268043A Amino-alkyl-amide derivatives as CCR3 receptor ligands
09/17/2008CN101268041A Sulphonamide derivatives
09/17/2008CN101265233A Radiation and chemotherapy sensitizing agent-glucosamine glycididazole and preparation method thereof
09/17/2008CN101265232A N-substituted-2-fluoroalkylimidazoline derivatives and synthesis method thereof
09/17/2008CN101265178A Amino acid salt of (S)-ibuprofen and medicinal composition thereof
09/16/2008US7425642 Anti-diabetic activity, improves insulin resistance and control the blood glucose level more safely, simulates activity of peroxisome proliferator-activated receptor; (1-{(2E)-3-[3-(Bromomethyl)phenyl]prop-2-en-1-yl}-1H-pyrrol-2-yl)(4-methyl-phenyl)methanone
09/16/2008US7425641 Carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions
09/16/2008US7425639 Process
09/16/2008US7425638 Cis-imidazolines
09/16/2008US7425631 Compounds and methods of use
09/16/2008US7425555 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors
09/16/2008US7425554 1,2-di(cyclic)substituted benzene compounds
09/16/2008CA2515338C Inhibitors of histone deacetylase
09/12/2008WO2008108221A1 Cyclic guanidine ionic liquid
09/12/2008WO2008073461A3 Ion channel modulators
09/12/2008WO2008052861A3 Method for producing 1,3-heteroaromatic carbonates
09/11/2008US20080221334 Process for the Preparation of Onium Alkylsulfonates
09/11/2008US20080221240 Functionalization of nanoscale articles including nanotubes and fullerenes
09/11/2008US20080221190 fungicides; good yields; steps require neither solvents nor reactants that are highly flammable and explosive, carcinogenic or corrosive; 1-chloro-4-chlorophenyl-2-butanol is reacted with the imidazole in toluene and aqueous sodium hydroxide solution in the presence of a phase transfer catalyst
09/11/2008US20080221186 4-(substituted cycloalkylmethyl) Imidazole-2-Thiones, 4-(substituted cycloalkenylmethyl) Imidazole-2-Thiones, 4-(substituted cycloalkylmethyl) Imidazol-2-Ones and 4-(substituted cycloalkenylmethyl) Imidazole-2-Ones and related compounds
09/11/2008US20080221181 Compounds for treating tumors
09/11/2008US20080221175 N-cyclohexyl benzamides and benzeneacetamides as inhibitors of 11-beta-hydroxysteroid dehydrogenases
09/11/2008US20080221169 3-carboxy aryl sulfonamide compounds, which agonize or antagonize aquaporin channels; brain trauma, head trauma, eye disorder, pulmonary disorder, lung disease, vascular disease, kidney disease, heavy metal toxicity, Alzheimer's disease, tumor, and cancer
09/10/2008EP1966154A1 Imidazole derivatives for the treatment of gastrointestinal disorders
09/10/2008EP1966153A1 (2,5-dioxoimidazolidin-i-yl)-n-hydroxy-acetamides as metalloproteinase inhibitors
09/10/2008EP1966130A2 Modified lysine-mimetic compounds
09/10/2008CN101263134A Midazole-4-carboxamide derivatives for use as CB modulators
09/10/2008CN101263122A 1,2-diarylimidazoles for use as CB1 modulators
09/10/2008CN101260081A Preparation method for N-arylazoles compounds
09/10/2008CN101260080A 3-(2-methyl-5-nitorimidazole)-1,2-propyl ester compound and its preparation method and use
09/10/2008CN100417379C Nonsedating alpha-2 agonist 1- (2, 3-dimethyl-phenyl) -ethyl-1, 3-dihydro-imizadole-2-thione
09/09/2008US7423177 Carboxamide derivatives as therapeutic agents
09/09/2008US7423158 2-Amino-5-[4-(difluoromethoxy)phenyl]-3-methyl-5-phenyl-3,5-dihydro-4H-imidazol-4-one; to treat beta-amyloid deposits and neurofibrillary tangles; neurodegenerative diseases like Alzheimer's disease, cognitive impairment, Down's Syndrome,senile dementia, cerebral amyloid angiopathy, degenerative dementia
09/09/2008US7423150 Substituted benzazoles and methods of their use as inhibitors of Raf kinase
09/09/2008US7423140 An acceptor fluorophore efficiently absorbs energy emission of a linked donor xanthene fluorophore labelling a oligonucleotide primer, reagent for sequencing nucleic acids, DNA sequencing
09/09/2008CA2181689C Guanylhydrazones for treating inflammatory conditions
09/04/2008WO2008106128A2 CYCLIC UREA AND CARBAMATE INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1
09/04/2008WO2008105565A1 Imidazole derivatives that induce apoptosis and their therapeutic uses
09/04/2008WO2008104942A2 Muscarinic receptor antagonists
09/04/2008WO2008104580A1 New use of glutaminyl cyclase inhibitors
09/04/2008WO2007126988A3 Selective androgen receptor modulators and methods of use thereof
09/04/2008US20080214673 e.g. Furan-3-carboxylic acid [(1R,3R)-3-(3-chloro-phenylethynyl)-3-hydroxy-cyclohexyl]-amide; metabotropic glutamate receptors modulator/antagonist;anxiolytic agent, antidepressant; amidation of amine-compounds
09/04/2008US20080214559 Compounds with a combination of cannabinoid cb1 antagonism and serotonin reuptake inhibition
09/04/2008US20080214448 Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide
09/04/2008US20080210907 Gelling agent, carbon nanotubes aqueous dispersing agent; simple synthesis from low cost, readily available raw materials; rapid elastic modulus recovery; environmentally friendly
09/04/2008CA2679446A1 New use of glutaminyl cyclase inhibitors
09/04/2008CA2678577A1 Cyclic urea and carbamate inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
09/03/2008EP1963279A1 Derivatives of 2-nitro-1,3-imidazole coupled to amino acids and deoxyribose useful for the detection of hypoxic biological tissue
09/03/2008EP1963278A1 Substituted imidazoline derivatives
09/03/2008EP1963277A1 Fluorinated compounds
09/03/2008EP1963255A1 Synephrine derivatives useful as anti-inflammatory agents
09/03/2008EP1962600A2 Metronidazole cocrystals and imipramine cocrystals
09/03/2008EP1704143B1 Malononitrile compound as pesticides
09/03/2008CN101258132A (2,5-dioxoimidazolidin-i-yl)-n-hydroxy-acetamides as metalloproteinase inhibitors
09/03/2008CN101255175A Secnidazole water-soluble salt and preparation method thereof
09/03/2008CN101255136A 5-cyclopropane toroid hydantoin derivatives as well as preparation method and uses thereof
09/03/2008CN100415748C A2B adenosine receptor antagonists
09/03/2008CN100415729C 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
09/02/2008US7420061 Process for preparing prodrugs of benzenesulfonamide-containing COX-2 inhibitors
09/02/2008US7420057 1-(2-(4-(3-trifluoromethyl-phenyl)piperazin-1-yl) ethyl)-2,3-dihydro-1H-benzimidazol-2-one (flibanserin); useful for treating psychological and nervous system disorders; prepared by heating a benzimidazolone compound with a piperazine derivative
09/02/2008US7420002 Amino acid conjugates providing for sustained systemic concentrations of GABA analogues
09/02/2008US7419997 e.g. N-(6-bromo-2,3,4,9-tetrahydro-1H-carbazol-1-yl)-2-fluorobenzenesulfonamide; viricide; papillomaviruses, polyomaviruses, retroviruses, papovaviruses, adenoviruses
09/02/2008US7419994 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2- thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cyloalkenylmethyl) imidazol-2-ones and related compounds
08/2008
08/28/2008WO2008103351A2 Heterocyclic aspartyl protease inhibitors
08/28/2008WO2008102359A1 Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins
08/28/2008WO2008101881A2 Alkyl h-phosphonates of n,n'-dialkylimidazoliums and of quaternary ammoniums, and uses thereof
08/28/2008WO2008030626A3 Skin compositions containing hydrocortisone
08/28/2008WO2007120173A3 N-halamine/quaternary ammonium polysiloxane copolymers
08/28/2008US20080207916 Radiolabelled Phenylethyl Imidazole Carboxylic Acid Ester Derivatives
1 ... 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 ... 345